Versant Capital Management’s Syndax Pharmaceuticals SNDX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $7.7K | Buy |
+822
| New | +$7.7K | ﹤0.01% | 2002 |
|
|
2025
Q1 | – | Sell |
-689
| Closed | -$9.11K | – | 2614 |
|
|
2024
Q4 | $9.11K | Buy |
+689
| New | +$9.11K | ﹤0.01% | 1450 |
|
|
2023
Q4 | – | Sell |
-10
| Closed | -$145 | – | 2006 |
|
|
2023
Q3 | $145 | Sell |
10
-13
| -57% | -$189 | ﹤0.01% | 1905 |
|
|
2023
Q2 | $481 | Buy |
+23
| New | +$481 | ﹤0.01% | 1842 |
|